This might be important, as tau, which accumulates in Alzheimer's disease, is a client protein of many chaperones and co-chaperones (Hsp90/CHIP and Hsp70 complexes), including CCT, that together control both its stabilization and degradation7. This evidence concerns the gene FLVCR2 and early-onset autosomal dominant Alzheimer disease.